Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer Xiaojia LiJie HeKeping Xie Review 15 March 2022 Pages: 201 - 225
How VEGF-A and its splice variants affect breast cancer development – clinical implications Hivin Al KawasInas SaaidMaria Margarete Karsten Review Open access 18 March 2022 Pages: 227 - 239
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma Marcell Costa de MedeirosMin LiuCarlos Rossa Jr Original Article Open access 10 March 2022 Pages: 241 - 256
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer Francesca De SantisSandra L. Romero-CordobaMassimo Di Nicola Original Article 31 March 2022 Pages: 257 - 274
Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway Jungwhoi LeeJungsul LeeJae-Hoon Kim Original Article 31 March 2022 Pages: 275 - 291
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer Ning ZhangYifeng LiaoHongyu Zhang Original Article 11 April 2022 Pages: 293 - 307
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells Yao ChenXiaoqin LuYongqing Liu Original Article Open access 11 April 2022 Pages: 309 - 321
PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer Laura BoyeroJoel Martin-PadronPedro P. Medina Short Communication 19 February 2022 Pages: 323 - 332
